Annual Drug Patent Expiration for AYVAKIT

New patent for Blueprint Medicines drug AYVAKIT – DrugPatentWatch

Less than a minute

Annual Drug Patent Expiration for AYVAKIT

Ayvakit is a drug marketed by Blueprint Medicines and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.

This drug has forty patent family members in thirty-one countries.

The generic ingredients in AYVAKIT are avapritinib. One registered supplier for this compound. Additional details are available on the avapritinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com